医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.

广告
第一作者: Lisa,Mayr
第一单位: Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.;Comprehensive Center for Pediatrics, General Hospital Vienna, Vienna, Austria.;Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria.
作者单位: Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.;Comprehensive Center for Pediatrics, General Hospital Vienna, Vienna, Austria.;Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria. [1] Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.;Comprehensive Center for Pediatrics, General Hospital Vienna, Vienna, Austria.;Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria.;Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. [2] Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria.;Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. [3] Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria.;Center of Cancer Research, Medical University of Vienna, Vienna, Austria. [4] Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA. [5] Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.;Comprehensive Center for Pediatrics, General Hospital Vienna, Vienna, Austria.;Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria.;Center of Cancer Research, Medical University of Vienna, Vienna, Austria. [6] Charles River Laboratories Germany GmbH, Freiburg, Germany. [7] Department of Neurosurgery, Johannes Kepler University, Kepler University Hospital Linz, Linz, Austria.;Clinical Research Institute for Neurosciences, Johannes Kepler University , Linz, Austria. [8] Department of Neurology, Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria. [9] Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.;German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.;National Center for Tumor Diseases (NCT), Heidelberg, Germany. [10] Children's Oncology Research Unit, Research Center, PSL Research University, Institut Curie, Paris, France.;SIRIC Laboratory of Translational Research in Pediatric Oncology, Translational Research Department, Research Center, PSL Research University, Paris, France. [11] Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.;German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.;National Center for Tumor Diseases (NCT), Heidelberg, Germany.;Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany. [12] Université Paris-Saclay, Inserm U1360, Gustave Roussy, Villejuif, France.;Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [13] Division of Clinical Studies, The Institute of Cancer Research, London, UK. [14] Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. [15] Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.;German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.;National Center for Tumor Diseases (NCT), Heidelberg, Germany.;Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. [16] Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria.;Department of Pathology, Medical University of Vienna, Vienna, Austria. [17] Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. johannes.gojo@meduniwien.ac.at.;Comprehensive Center for Pediatrics, General Hospital Vienna, Vienna, Austria. johannes.gojo@meduniwien.ac.at.;Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria. johannes.gojo@meduniwien.ac.at. [18] Comprehensive Cancer Center, General Hospital Vienna, Vienna, Austria. daniela.loetsch@meduniwien.ac.at.;Department of Neurosurgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. daniela.loetsch@meduniwien.ac.at. [19]
DOI 10.1186/s13046-026-03725-3
PMID 42143334
发布时间 2026-07-09
提交
  • 浏览0
Journal of experimental & clinical cancer research : CR

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷